Alembic Pharma gets USFDA nod for generic chronic iron overload treatment tablets

The company has received the final approval from the United States Food& Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Deferasirox tablets in the strength of 180 mg, Alembic Pharmaceuticals said in a BSE filing.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news